BDR Pharma launches generic antibiotic range medicine, Ceftazidime Avibactum
XAVITAZ is useful in treating resistant gram-negative infections, including many Ceftazidime-resistant strains
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BDR Pharmaceuticals
BDR Pharmaceuticals announces license agreement with DRDO to manufacture 2-DG drug in India
Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy…
BDR Pharma to launch 400 mg Favipiravir tablets
The 400 mg tablets will be priced at Rs 990 for a strip of 10 tablets
Experts ask govt to ensure access to remdesivir, raise concerns about supply shortage
Many also allude to an emerging black market for remdesivir in the country through which the drug is being sold at exorbitant…
CDSCO to inspect BDR Pharma’s formulation facility, submit report in seven days
It is part of fast-tracking manufacturing and marketing applications of remdesivir, informs CDSCO
BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir
The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in…